Gazzard, Lewis J.,Williams, Karen,Goodacre, Simon Charles,Macleod, Calum,Lyssikatos, Joseph P.,Dyke, Hazel Joan,Gancia, Emanuela,Chen, Huifen
申请号：
AU2009258115
公开号：
AU2009258115B2
申请日:
2009.06.10
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The invention relates to 1,5-diazacarbazole compounds of Formula (I), (I-a), (I-b), (I-c), (I-d), (I-e), (I-f), (I-g) and (I-h) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chkl) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for
